AXE

2.38%

21.5¢ archer materials limited

AXE AGM, page-8

First 8 Last

Share
Profile

Follow
SneakyMercator

115 Posts.

22

04/12/20

17:56

Post #: 49356000
Share

Originally posted by Tonza: ↑

Hey GM,

Below is the link to the AGM Video. Haven't had a chance to view yet - been a busy boy with a number of projects on the go so didn't attend the Virtual AGM either. Seems everything is going well and still alot happening in the background. Thinking the remaining approvals for the mining permits for Campoona Graphite Mine would be due soon ( it's been 12 months - don't believe AXE will be mining this resource as they are moving away from mining and exploration, but could be a deal or joint venture down the track. Have the feeling the reliable energy vertical with have more to do with New Graphene materials to be incorporated into battery chemistry rather than using Campoona and developing Spherical Graphite ( hence the IP's they are working on ) - Mohammad keeps alluding to changing material properties on the molecular level to create new advanced materials. Having met Mohammad and spending time with him I would not underestimate his knowledge of chemistry and nano science. He is also surrounded by some highly talented professionals in their respective fields. I would consider Mo one very intelligent and determined individual - knows what's required and has the determination and knowhow to get there.

Looking at the trading, looks as though shares are tightly held here. 2020 for AXE has worked out well considering the events during the year. Still some way to go but they are being internationally recognized and still progressing their goals. I'm assuming the latest ad on seek for the Bio Technology Development is to assist Rebecca in the Nano science foundry accelerating the the lab on a chip development ( interesting we took development to a whole new level so quickly by now using the nano science foundry to progress the chip development ! )

Although the deal for Leigh creek seems disappointing - the money is not required for a long time yet and this is a market and shares rise and fall so I'm not considering this of any importance at this stage. If milestones and the progression of 12cq and the Bio Sensor Development continues it's positive advancement this may possibly have no relevance at all later. As Mo has mentioned before value will be derived within the progress on these verticals rather than just at the final product stage. Due to the disruptive nature of these technologies, and with further major milestones achieved and surpassed then the attention focusing on AXE one would think would only intensify.

I'm very much liking what I'm seeing and trading seems to indicate others are happy to accept the risk and hold tight also. I'll be here for a longtime yet and I'm looking forward to this story gradually unfolding. I would not hype what they are doing as it's a long road and still a risk, but it is incredibly exciting stuff what they are aiming towards. I think AXE is more akin to Investors than traders, although opportunity's do arise every now and again. It's not hard to see by the Buy/ Sell stack that accumulation is defiantly happening.

I'm feeling there will be more focus on advancing our manufacturing capabilities and technologies here in Australia and companies like AXE has a big role to play in advancing Australia in the future.

As always, all the best in however you invest or trade Archer and well done to all of us with helping to keep covid at bay! It been a trying year and Australia is in a fortunate position - lets keep it that way!
Take care

Cheers
Tonza

Expand

Thanks Tonza,

Very happy with the route Archer is taking, might pick up some more next week.

Unfortunately I don't think we will be getting anything for Christmas, although I think we might be in for a surprise start of 2021.

AXE Price at posting: 53.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

There are more pages in this discussion • 3 more messages in this thread...

First 8 Last

Add AXE (ASX) to my watchlist

(20min delay)
Last 21.5¢		Change 0.005(2.38%)		Mkt cap ! $54.79M

Open	High	Low	Value	Volume
21.5¢	23.0¢	21.0¢	$87.37K	399.3K

Buyers (Bids)

No.	Vol.	Price($)
1	2400	21.5¢

Sellers (Offers)

Price($)	Vol.	No.
23.0¢	331934	2

View Market Depth

No.	Vol.	Price($)
1	2400	0.215
4	111772	0.210
6	135726	0.205
10	63300	0.200
2	20130	0.195

Price($)	Vol.	No.
0.230	134834	1
0.240	37777	4
0.245	30000	2
0.250	8150	2
0.255	28300	2

Last trade - 15.55pm 04/10/2024 (20 minute delay)

AXE (ASX) Chart

AXE AGM, page-8

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

AXE AGM, page-8

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News